ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2026 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Digitalis Purpurea

Also known as: Foxglove, Purple Foxglove, Digitalis purpurea

Overview

*Digitalis purpurea*, commonly known as foxglove, is a flowering plant native to Europe and parts of Asia. It is primarily known for its cardiac glycosides, including digoxin and digitoxin, which are used in the medical management of heart conditions like heart failure and atrial fibrillation. This herb has been utilized historically for its ability to improve the strength of cardiac contractions and regulate heart rhythm, thus playing a crucial role in cardiovascular therapy. The plant contains several bioactive compounds, the efficacy of which has been extensively researched. Findings related to its therapeutic use are reinforced by high-quality evidence from various clinical trials and systematic reviews. Although it presents significant benefits, the use of *Digitalis purpurea* must be carefully controlled due to its narrow therapeutic index, which poses risks of toxicity.

Benefits

The major benefit of *Digitalis purpurea* lies in its ability to enhance the force of myocardial contractions, making it useful in treating heart failure and controlling heart rate in atrial fibrillation. Clinical evidence supports the use of digoxin, a key component, in reducing hospitalizations for heart failure patients. Its effectiveness may vary based on the specific condition and individual patient characteristics. Additionally, preliminary studies suggest potential antioxidant and anti-inflammatory benefits, though these effects are not as well-documented. Importantly, the therapeutic effects typically manifest within 30 minutes to 2 hours of administration, with peak effects observed between 2 to 6 hours.

How it works

*Digitalis purpurea* exerts its effects primarily through the inhibition of the sodium-potassium ATPase pump in cardiac myocytes. This inhibition leads to increased intracellular sodium levels, resulting in elevated intracellular calcium concentrations, which enhances cardiac contractility. By promoting more forceful contractions while simultaneously slowing the heart rate, the glycosides present in the plant effectively improve cardiac output and rhythm regulation. The primary physiological target remains the cardiovascular system, though electrolyte imbalances can influence the nervous system and overall heart function.

Side effects

*Digitalis purpurea* has a narrow therapeutic index, which necessitates careful monitoring of doses. Common side effects include nausea, vomiting, headache, and visual disturbances. Less frequently, patients may experience fatigue, confusion, and serious conditions such as arrhythmias. Rarely, severe ventricular fibrillation can occur, underscoring the importance of monitoring. The risk of toxicity is particularly elevated in patients taking diuretics, beta-blockers, or calcium channel blockers concurrently, as well as in those with significant renal impairment or certain types of arrhythmias like Wolff-Parkinson-White syndrome. Elderly patients must use this medication with caution due to altered pharmacokinetics.

Dosage

The typical minimum effective dose of digoxin for managing heart failure starts at approximately 0.125 mg per day, while higher doses up to 0.25 mg per day may be necessary for atrial fibrillation. It is generally advised not to exceed 0.25 mg daily to avoid toxicity. For optimal results, patients should take digoxin consistently at the same time each day, typically in oral form, which is more common for chronic use than intravenous routes. Absorption may be influenced by food intake and interactions with other medications, highlighting the need for individualized treatment plans and periodic serum level monitoring.

FAQs

How should I monitor the use of Digitalis?

Regular monitoring of serum digoxin levels and electrolytes is essential to prevent toxicity associated with Digitalis.

What are the risks of taking Digitalis?

The primary risks include toxicity if not monitored appropriately, especially in patients with kidney issues or those on certain medications.

When is the best time to take Digitalis?

It should be taken consistently at the same time each day for optimal effect.

What improvements can I expect from Digitalis?

Patients typically experience symptom relief in heart failure and a more stable heart rhythm in atrial fibrillation.

Is Digitalis a cure for heart failure?

No, Digitalis is used to manage symptoms but is not a cure for heart failure.

Research Sources

  • https://www.mdpi.com/2077-0383/12/4/1686 – This study presents a systematic review indicating that digitalis therapy may influence mortality outcomes in certain patient populations, specifically those with implantable cardiac devices.
  • https://www.frontiersin.org/journals/plant-science/articles/10.3389/fpls.2024.1433634/full – Research has evaluated the bioactive compounds of *Digitalis purpurea*, suggesting potential for new therapeutic discoveries based on its unique compounds, although direct human health benefits remain to be clarified.
  • https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0277293 – Clinical trials outlined in this article demonstrate that digoxin effectively reduces hospitalizations for patients with heart failure, emphasizing the importance of careful dosing due to toxicity risks.

Supplements Containing Digitalis Purpurea

Ki-HearteXX by Viatrexx Bio Incorporated
23

Ki-HearteXX

Viatrexx Bio Incorporated

Score: 23/100